Thanks @Lefevre . I’m personally most hopeful about the...

Thanks @Lefevre . I’m personally most hopeful about the partnership with Abiomed.

The way I see it, all the revenues generated thus far from Abiomed has been R&D revenue. I have gone through almost every single Abiomed announcement over the last year and gather that there are only just starting to market Impella CP with a SmartAssist and optical sensor. It’s actually one of their “new frontier” products only now mentioned along with their base products being Impella 2.5, Impella 5.0, Impella 5.5, Impella RP, and Impella CP.

My take is that SmartAssist and Optical Sensor will be integrated into all base products but FDA approval will come bit by bit. Impella BTR also includes fluidic sensors and is another pipeline product.

Once all products are integrated with Sensera technology and gain PMA approval, we will see a massive spike in revenues. For now, Impella CP with SmartAssist and Optical Sensor will provide the commercial revenues.

Watch this space I reckon.